Viva Biotech Holdings (VBIZF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 866.89 Million CNY | -59.57% |
| 2022 | 2.14 Billion CNY | 15.68% |
| 2021 | 1.85 Billion CNY | 180.42% |
| 2020 | 661.05 Million CNY | 177.35% |
| 2019 | -854.68 Million CNY | -457.92% |
| 2018 | -153.19 Million CNY | -933.61% |
| 2017 | -14.82 Million CNY | -49.42% |
| 2016 | -9.91 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 475.43 Million CNY | 0.0% |
| 2024 Q1 | 475.43 Million CNY | -45.16% |
| 2023 FY | 866.89 Million CNY | -59.57% |
| 2023 Q1 | 1.82 Billion CNY | -14.78% |
| 2023 Q4 | 866.89 Million CNY | 0.34% |
| 2023 Q3 | 863.96 Million CNY | -52.82% |
| 2023 Q2 | 1.83 Billion CNY | 0.2% |
| 2022 Q4 | 2.14 Billion CNY | 0.11% |
| 2022 FY | 2.14 Billion CNY | 15.68% |
| 2022 Q3 | 2.14 Billion CNY | 2.13% |
| 2022 Q2 | 2.09 Billion CNY | 0.11% |
| 2022 Q1 | 2.09 Billion CNY | 13.03% |
| 2021 Q1 | 1.69 Billion CNY | 157.07% |
| 2021 Q3 | 1.84 Billion CNY | 8.08% |
| 2021 Q4 | 1.85 Billion CNY | 0.31% |
| 2021 FY | 1.85 Billion CNY | 180.42% |
| 2021 Q2 | 1.7 Billion CNY | 0.62% |
| 2020 Q3 | 649.64 Million CNY | 168.63% |
| 2020 FY | 661.05 Million CNY | 177.35% |
| 2020 Q1 | -957.49 Million CNY | -12.03% |
| 2020 Q4 | 661.05 Million CNY | 1.76% |
| 2020 Q2 | -946.57 Million CNY | 1.14% |
| 2019 Q3 | -879.14 Million CNY | 26.44% |
| 2019 Q1 | -1.21 Billion CNY | -694.45% |
| 2019 FY | -854.68 Million CNY | -457.92% |
| 2019 Q4 | -854.68 Million CNY | 2.78% |
| 2019 Q2 | -1.19 Billion CNY | 1.8% |
| 2018 FY | -153.19 Million CNY | -933.61% |
| 2018 Q3 | 67.4 Million CNY | 0.0% |
| 2018 Q1 | 33.26 Million CNY | 0.0% |
| 2018 Q4 | -153.19 Million CNY | -327.26% |
| 2017 FY | -14.82 Million CNY | -49.42% |
| 2016 FY | -9.91 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 128893.518% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | -71314.743% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -85925.726% |
| Evofem Biosciences, Inc. | 42.79 Million USD | -1925.787% |
| GB Sciences, Inc. | 1.74 Million USD | -49512.949% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 9906.602% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 9353393.038% |
| Skye Bioscience, Inc. | -5.72 Million USD | 15251.828% |
| Zenith Capital Corp. | 10.06 Thousand USD | -8613721.542% |
| Agentix Corp. | 37.63 Thousand USD | -2303572.504% |
| Arch Therapeutics, Inc. | 5.64 Million USD | -15247.702% |
| Biomind Labs Inc. | 711.4 Thousand USD | -121757.262% |
| ContraFect Corporation | -6.02 Million USD | 14485.911% |
| CSL Limited | 10.52 Billion USD | 91.764% |
| CytoDyn Inc. | 20.26 Million USD | -4178.428% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -240898.304% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -139190.672% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | -1895.89% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 4247919.483% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -93397.421% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -136383.004% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 13850.364% |
| SQZ Biotechnologies Company | -36.23 Million USD | 2492.226% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -100673.504% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | -5399.556% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | -38562.128% |
| Mesoblast Limited | 55.85 Million USD | -1451.955% |
| Marizyme, Inc. | 18.56 Million USD | -4568.499% |
| Genus plc | 190.6 Million USD | -354.824% |
| Pharming Group N.V. | 109.8 Million USD | -689.493% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -127384.559% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | -74927.977% |
| IMV Inc. | 7.67 Million USD | -11201.644% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | -15656.296% |
| MultiCell Technologies, Inc. | 90.04 USD | -962788660.551% |
| ONE Bio Corp. | 9.04 Million USD | -9489.509% |
| RVL Pharmaceuticals plc | 12.94 Million USD | -6596.238% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | -2737.255% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | -43257.931% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | -6669.132% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -619978.825% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -4363392.223% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 471782.047% |
| Enzolytics Inc. | 981.65 Thousand USD | -88209.449% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -2.02 Billion USD | 142.729% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 1943.987% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -12159.913% |
| Genscript Biotech Corporation | -1.06 Billion USD | 181.68% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | -20951.237% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -215626.554% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | -36232.047% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -526859.011% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 4732576.253% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | -38672.815% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -643766.19% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 118209.126% |
| Helix BioMedix, Inc. | -2.57 Million USD | 33830.903% |
| EV Biologics, Inc. | 1.36 Million USD | -63270.861% |
| Q BioMed Inc. | 4.06 Million USD | -21252.052% |
| Capstone Therapeutics Corp. | 20.27 Million USD | -4175.473% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | -1331.802% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 4.47 Million USD | -19284.903% |
| Curative Biotechnology, Inc. | 2.2 Million USD | -39268.868% |
| HST Global, Inc. | 96.79 Thousand USD | -895517.452% |
| Burzynski Research Institute, Inc. | -1310.00 USD | 66175290.84% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -420279.988% |
| Halberd Corporation | 144.72 Thousand USD | -598911.201% |
| Resverlogix Corp. | 6.45 Million USD | -13338.149% |
| Cell Source, Inc. | 9.23 Million USD | -9290.14% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -31905.102% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | -5.9 Million USD | 14785.153% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -432413.271% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 2.17 Million USD | -39693.846% |
| Kadimastem Ltd | -253.1 Thousand USD | 342608.159% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -637374.355% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -430646.718% |
| LadRx Corporation | -2.03 Million USD | 42668.534% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -136383.004% |
| Affymax, Inc. | -5.59 Million USD | 15588.565% |
| Itoco Inc. | 228.3 Thousand USD | -379609.161% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | -17388.299% |
| Mobile Lads Corp. | 484.23 Thousand USD | -178924.724% |
| International Stem Cell Corporation | 2.59 Million USD | -33370.849% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | 1.89 Million USD | -45552.146% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 133986962.442% |
| Qrons Inc. | 351.42 Thousand USD | -246578.542% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | -11149.608% |
| SYBLEU INC | 473.71 Thousand USD | -182899.658% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 347385.875% |
| Rebus Holdings, Inc. | 305 Thousand USD | -284127.869% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | -19350.095% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -1388865.44% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -39649.415% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | -25144.467% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | -10035.566% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -112103.876% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 69451.6% |
| Neutra Corp. | 52.18 Thousand USD | -1661032.083% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 34929.048% |
| PureTech Health plc | -167.19 Million USD | 618.487% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 354067.612% |
| IXICO plc | -4.44 Million USD | 19604.512% |
| IntelGenx Technologies Corp. | 13.21 Million USD | -6457.947% |
| Gelesis Holdings, Inc. | 54.85 Million USD | -1480.454% |
| CSL Limited | 10.52 Billion USD | 91.764% |
| Cellectis S.A. | -43.81 Million USD | 2078.36% |